|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/517 | |
| A61K 31/495 | |||
| A61K 31/395 | |||
| A61P 35/00 | |||
| A61P 35/04 | |||
| A61P 25/00 | |||
| A61P 43/00 | |||
| A61K 9/00 | |||
| A61K 45/06 | |||
| C07D 403/12 |
| (11) | Number of the document | 3116507 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15760794.6 |
| Date of filing the European patent application | 2015-03-10 | |
| (97) | Date of publication of the European application | 2017-01-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/019658 |
| Date | 2015-03-10 |
| (87) | Number | WO 2015/138420 |
| Date | 2015-09-17 |
| (30) | Number | Date | Country code |
| 201461950707 P | 2014-03-10 | US |
| (72) |
WAKSAL, Samuel, D., US
|
| (73) |
Kadmon Corporation, LLC,
450 East 29th Street, New York, NY 10016,
US
|
| (54) | COMPOUNDS FOR ORAL TREATMENT OF BRAIN TUMORS |
| COMPOUNDS FOR ORAL TREATMENT OF BRAIN TUMORS |